The stock is in a powerful, sustained uptrend, evidenced by a staggering 1-year price change of +877.94%. As of the latest close at $75.79, the price is trading at approximately 94% of its 52-week range ($7.47 to $80.27), positioning it near all-time highs which signals extreme momentum but also raises concerns about potential overextension and vulnerability to a sharp correction. Recent momentum remains exceptionally strong but shows signs of volatility; the 3-month return of +72.52% significantly outpaces the 1-month gain of +5.63%, indicating that while the longer-term trend is intact, the pace of ascent has moderated recently, possibly entering a consolidation phase after the explosive move from February to March 2026.

The short-term momentum divergence is notable, with the 1-month return of +5.63% being positive but paling in comparison to the preceding months, suggesting a potential cooling-off period or profit-taking. This is further contextualized by the stock's extreme beta of 2.27, indicating it is more than twice as volatile as the broader market, which explains the violent swings observed in the price data, such as the drop from above $71 to $54 in late March before a rapid recovery. Key technical levels are clear: immediate resistance is at the 52-week high of $80.27, a breakout above which could signal a continuation of the parabolic move, while a breakdown below the recent swing low near $54 (from March 30) would suggest a deeper correction is underway, with the ultimate safety net being the 52-week low of $7.47, though a retracement to that level seems improbable barring a complete narrative collapse.

Support and resistance analysis is challenging given the stock's meteoric rise, but the 52-week high of $80.27 serves as the primary resistance, while the March 30 low of $54.00 and the 50-day moving average (implied by the price trend) around $60 could act as dynamic support zones. The stock's beta of 2.27 confirms its status as a high-risk, high-volatility instrument; this extreme volatility necessitates careful position sizing, as moves of 10-20% in a short period are commonplace, as seen in the price data where the stock fell -27.07% from its peak in a matter of days in March.

Revenue is on a strong growth trajectory, with the most recent quarterly revenue (Q4 2025) reaching $81.185 million, representing a robust 71.35% year-over-year growth. This acceleration is clear when examining the sequential quarterly trend: revenue grew from $51.668 million in Q1 2025 to $81.185 million in Q4 2025, indicating sustained quarter-over-quarter expansion. Segment data reveals the Aerospace and Defense segment is the primary growth driver, contributing $56.298 million in the latest period, significantly outpacing the Industrial ($10.668 million) and Microfabrication ($14.219 million) segments, underscoring the company's leverage to defense spending.

The company remains unprofitable on a net income basis, reporting a Q4 2025 net loss of $4.909 million, which translates to an EPS of -$0.10. However, profitability metrics are showing marked improvement; the gross margin for Q4 2025 was 30.74%, a significant recovery from the severely depressed 2.39% gross margin in Q4 2024, and the net margin improved to -6.05% from -52.68% over the same period. The operating margin remains negative at -6.66% for Q4 2025, but the trend is positive, moving from an abysmal -55.78% in Q4 2024, indicating the company is on a path toward operational breakeven as sales scale.

The balance sheet is healthy with a strong liquidity position, evidenced by a current ratio of 3.79 and a low debt-to-equity ratio of 0.16, indicating minimal financial leverage risk. The company generated positive free cash flow on a TTM basis of $12.298 million, and the latest quarterly cash flow statement shows operating cash flow of $17.518 million and free cash flow of $15.93 million for Q4 2025. With cash and equivalents of $99.021 million as of Q4 2025 and an ROE of -10.35%, the financial health is solid, providing a cushion to fund growth and weather potential downturns without immediate need for dilutive financing.